Autor: "Yan, Y" - OpacWWW - Prolib Integro

Skocz do pozycji: 1.

Tytuł:: Integrated single-cell transcriptomics reveals the hypoxia-induced inflammation-cancer transformation in NASH-derived hepatocellular carcinoma.
Autorzy:: Liang Y; Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Research Unit of Liver Transplantation and Transplant Immunology, Chinese Academy of Medical Sciences, Nanjing Medical University, Nanjing, China.; School of Biological Science & Medical Engineering, Southeast University, Nanjing, China.
Zhang R; Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Research Unit of Liver Transplantation and Transplant Immunology, Chinese Academy of Medical Sciences, Nanjing Medical University, Nanjing, China.
Biswas S; Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Research Unit of Liver Transplantation and Transplant Immunology, Chinese Academy of Medical Sciences, Nanjing Medical University, Nanjing, China.
Bu Q; Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Research Unit of Liver Transplantation and Transplant Immunology, Chinese Academy of Medical Sciences, Nanjing Medical University, Nanjing, China.
Xu Z; Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Research Unit of Liver Transplantation and Transplant Immunology, Chinese Academy of Medical Sciences, Nanjing Medical University, Nanjing, China.
Qiao L; Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Research Unit of Liver Transplantation and Transplant Immunology, Chinese Academy of Medical Sciences, Nanjing Medical University, Nanjing, China.; Department of Bioinformatics, Nanjing Medical University, Nanjing, China.
Zhou Y; Department of Pancreatic Surgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China.
Tang J; Department of Bioinformatics, Nanjing Medical University, Nanjing, China.
Zhou J; Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Research Unit of Liver Transplantation and Transplant Immunology, Chinese Academy of Medical Sciences, Nanjing Medical University, Nanjing, China.
Zhou H; Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Research Unit of Liver Transplantation and Transplant Immunology, Chinese Academy of Medical Sciences, Nanjing Medical University, Nanjing, China.
Lu L; Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Research Unit of Liver Transplantation and Transplant Immunology, Chinese Academy of Medical Sciences, Nanjing Medical University, Nanjing, China.; Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.; Pokaż więcej
Źródło:: Cell proliferation [Cell Prolif] 2024 Apr; Vol. 57 (4), pp. e13576. Date of Electronic Publication: 2023 Nov 22.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Hepatocellular*/pathology
Non-alcoholic Fatty Liver Disease*/genetics
Non-alcoholic Fatty Liver Disease*/metabolism
Liver Neoplasms*/pathology
Animals ; Mice ; Inflammation/genetics ; Cell Transformation, Neoplastic/genetics ; Gene Expression Profiling ; Tumor Microenvironment

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: HBV DNA polymerase upregulates the transcription of PD-L1 and suppresses T cell activity in hepatocellular carcinoma.
Autorzy:: Jia Y; Department of Laboratory Medicine, Tianjin Hospital, Tianjin, 300211, China.
Zhao J; Department of Pathology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, 050011, China.
Wang C; Department of Clinical Laboratory Medicine, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Shandong Medicine and Health Key Laboratory of Laboratory Medicine, Jinan, 250014, China.
Meng J; Department of Clinical Laboratory, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250033, China.
Zhao L; Department of Pediatrics, Zaozhuang Municipal Hospital, Zaozhuang, 277100, China.
Yang H; Department of Laboratory Medicine, Tianjin Hospital, Tianjin, 300211, China.
Zhao X; Department of Clinical Laboratory, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250033, China. .; Pokaż więcej
Źródło:: Journal of translational medicine [J Transl Med] 2024 Mar 12; Vol. 22 (1), pp. 272. Date of Electronic Publication: 2024 Mar 12.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Hepatocellular*/pathology
Liver Neoplasms*/pathology
Mice ; Animals ; Hepatitis B virus/genetics ; DNA, Viral ; B7-H1 Antigen/metabolism ; CD8-Positive T-Lymphocytes ; DNA-Directed DNA Polymerase/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Routine evaluation of HBV-specific T cell reactivity in chronic hepatitis B using a broad-spectrum T-cell epitope peptide library and ELISpot assay.
Autorzy:: Wu Y; Department of Microbiology and Immunology, Medical School of Southeast University, Nanjing, 210009, Jiangsu, China.
Liu X; Department of Microbiology and Immunology, Medical School of Southeast University, Nanjing, 210009, Jiangsu, China.
Mao Y; Nanjing KingMed Clinical Laboratory, Nanjing, 211899, Jiangsu, China.
Ji R; Department of Microbiology and Immunology, Medical School of Southeast University, Nanjing, 210009, Jiangsu, China.
Xia L; Nanjing KingMed Clinical Laboratory, Nanjing, 211899, Jiangsu, China.
Zhou Z; Department of Microbiology and Immunology, Medical School of Southeast University, Nanjing, 210009, Jiangsu, China.
Ding Y; Department of Microbiology and Immunology, Medical School of Southeast University, Nanjing, 210009, Jiangsu, China.
Li P; Division of Hepatitis, Nanjing Second Hospital, Nanjing Hospital affiliated to Nanjing University of Chinese Medicine, Nanjing, 210003, Jiangsu, China.
Zhao Y; Department of Microbiology and Immunology, Medical School of Southeast University, Nanjing, 210009, Jiangsu, China.
Peng M; Department of Microbiology and Immunology, Medical School of Southeast University, Nanjing, 210009, Jiangsu, China.
Qiu J; Division of Hepatitis, Nanjing Second Hospital, Nanjing Hospital affiliated to Nanjing University of Chinese Medicine, Nanjing, 210003, Jiangsu, China. .
Shen C; Department of Microbiology and Immunology, Medical School of Southeast University, Nanjing, 210009, Jiangsu, China. .; Pokaż więcej
Źródło:: Journal of translational medicine [J Transl Med] 2024 Mar 11; Vol. 22 (1), pp. 266. Date of Electronic Publication: 2024 Mar 11.
Typ publikacji:: Journal Article
MeSH Terms:: Hepatitis B, Chronic*
Carcinoma, Hepatocellular*
Liver Neoplasms*
Humans ; Hepatitis B virus ; Hepatitis B Surface Antigens ; Hepatitis B e Antigens ; Peptide Library ; Epitopes, T-Lymphocyte/therapeutic use ; Liver Cirrhosis ; DNA, Viral

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Pan-cancer and multi-omics analyses revealed the diagnostic and prognostic value of BAZ2A in liver cancer.
Autorzy:: Liu Y; College of Life Science, North China University of Science and Technology, Tangshan, 063210, China.; Hebei Key Laboratory of Molecular Oncology, Tangshan, 063001, China.
Wang J; College of Life Science, North China University of Science and Technology, Tangshan, 063210, China.
Guo J; College of Life Science, North China University of Science and Technology, Tangshan, 063210, China.
Zhang Q; College of Life Science, North China University of Science and Technology, Tangshan, 063210, China.
Wang S; School of Public Health, North China University of Science and Technology, Tangshan, 063210, China.; Hospital of North China University of Science and Technology, Tangshan, 063210, China.
Hu F; College of Life Science, North China University of Science and Technology, Tangshan, 063210, China.
Wu J; Department of Clinical Laboratory, North China University of Science and Technology Affiliated Tangshan Maternal and Child Health Hospital, Tangshan, 063000, China.
Zhao Y; Department of Breast Center, North China University of Science and Technology Affiliated Hospital, Tangshan, 063210, China.
Zhang J; Hebei Key Laboratory of Molecular Oncology, Tangshan, 063001, China. jhzhang_.; School of Public Health, North China University of Science and Technology, Tangshan, 063210, China. jhzhang_.; Department of Clinical Laboratory, North China University of Science and Technology Affiliated Tangshan Maternal and Child Health Hospital, Tangshan, 063000, China. jhzhang_.
Yu Y; College of Life Science, North China University of Science and Technology, Tangshan, 063210, China. .
Li Y; Hebei Key Laboratory of Molecular Oncology, Tangshan, 063001, China. .; The Cancer Institute, Tangshan People's Hospital, Tangshan, 063001, China. .
Zhang X; Department of Oncology, People's Hospital of Zunhua, Tangshan, 064200, China. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Mar 04; Vol. 14 (1), pp. 5228. Date of Electronic Publication: 2024 Mar 04.
Typ publikacji:: Journal Article
MeSH Terms:: Multiomics*
Liver Neoplasms*/diagnosis
Liver Neoplasms*/genetics
Humans ; Prognosis ; Carcinogenesis ; Cell Transformation, Neoplastic ; Bromodomain Containing Proteins ; Chromosomal Proteins, Non-Histone

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: AMPKα2 promotes tumor immune escape by inducing CD8+ T-cell exhaustion and CD4+ Treg cell formation in liver hepatocellular carcinoma.
Autorzy:: Ouyang Y; Key Laboratory of Infectious Immune and Antibody Engineering of Guizhou Province, Engineering Research Center of Cellular Immunotherapy of Guizhou Province, Guizhou Medical University, Guiyang, China.
Gu Y; Key Laboratory of Infectious Immune and Antibody Engineering of Guizhou Province, Engineering Research Center of Cellular Immunotherapy of Guizhou Province, Guizhou Medical University, Guiyang, China.
Zhang X; Key Laboratory of Infectious Immune and Antibody Engineering of Guizhou Province, Engineering Research Center of Cellular Immunotherapy of Guizhou Province, Guizhou Medical University, Guiyang, China.
Huang Y; Immune Cells and Antibody Engineering Research Center of Guizhou Province, Key Laboratory of Biology and Medical Engineering, Guizhou Medical University, Guiyang, China.
Wei X; Key Laboratory of Infectious Immune and Antibody Engineering of Guizhou Province, Engineering Research Center of Cellular Immunotherapy of Guizhou Province, Guizhou Medical University, Guiyang, China.
Tang F; Immune Cells and Antibody Engineering Research Center of Guizhou Province, Key Laboratory of Biology and Medical Engineering, Guizhou Medical University, Guiyang, China. .
Zhang S; Immune Cells and Antibody Engineering Research Center of Guizhou Province, Key Laboratory of Biology and Medical Engineering, Guizhou Medical University, Guiyang, China. .; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2024 Mar 01; Vol. 24 (1), pp. 276. Date of Electronic Publication: 2024 Mar 01.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Hepatocellular*/genetics
Liver Neoplasms*/genetics
Humans ; AMP-Activated Protein Kinases ; CD4-Positive T-Lymphocytes ; CD8-Positive T-Lymphocytes ; T-Cell Exhaustion ; T-Lymphocytes, Regulatory ; Tumor Escape

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Mesoporous Silicon Nanoparticles with Liver-Targeting and pH-Response-Release Function Are Used for Targeted Drug Delivery in Liver Cancer Treatment.
Autorzy:: Wei J; Guangdong Provincial University Engineering Technology Research Center of Natural Products and Drugs, Guangdong Pharmaceutical University, Guangzhou 510006, China.; Guangdong Metabolic Disease Research Center of Integrated Chinese and Western Medicine, Guangdong Pharmaceutical University, Guangzhou 510006, China.
Tan Y; Guangdong Provincial University Engineering Technology Research Center of Natural Products and Drugs, Guangdong Pharmaceutical University, Guangzhou 510006, China.; Guangdong Metabolic Disease Research Center of Integrated Chinese and Western Medicine, Guangdong Pharmaceutical University, Guangzhou 510006, China.
Bai Y; School of Public Health, Guangdong Pharmaceutical University, Guangzhou 510310, China.
He J; School of Public Health, Guangdong Pharmaceutical University, Guangzhou 510310, China.
Cao H; School of Chemistry and Chemical Engineering, Guangdong Pharmaceutical University, Zhongshan 528458, China.
Guo J; Guangdong Metabolic Disease Research Center of Integrated Chinese and Western Medicine, Guangdong Pharmaceutical University, Guangzhou 510006, China.
Su Z; Guangdong Provincial University Engineering Technology Research Center of Natural Products and Drugs, Guangdong Pharmaceutical University, Guangzhou 510006, China.; Guangdong Metabolic Disease Research Center of Integrated Chinese and Western Medicine, Guangdong Pharmaceutical University, Guangzhou 510006, China.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2024 Feb 21; Vol. 25 (5). Date of Electronic Publication: 2024 Feb 21.
Typ publikacji:: Journal Article
MeSH Terms:: Nanoparticles*/chemistry
Liver Neoplasms*
Humans ; Silicon ; Drug Carriers/chemistry ; Drug Delivery Systems ; Silicon Dioxide/chemistry ; Hydrogen-Ion Concentration ; Galactosamine

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Potential crosstalk between SPP1 + TAMs and CD8 + exhausted T cells promotes an immunosuppressive environment in gastric metastatic cancer.
Autorzy:: Du Y; Department of Gastroenterological Surgery, Peking University People's Hospital, Beijing, China.; Beijing Key Laboratory of Colorectal Cancer Diagnosis and Treatment Research, Beijing, China.
Lin Y; Department of Gastroenterological Surgery, Peking University People's Hospital, Beijing, China.; Beijing Key Laboratory of Colorectal Cancer Diagnosis and Treatment Research, Beijing, China.
Gan L; Department of Gastroenterological Surgery, Peking University People's Hospital, Beijing, China.; Beijing Key Laboratory of Colorectal Cancer Diagnosis and Treatment Research, Beijing, China.
Wang S; Department of Gastroenterological Surgery, Peking University People's Hospital, Beijing, China.; Beijing Key Laboratory of Colorectal Cancer Diagnosis and Treatment Research, Beijing, China.
Chen S; Department of Gastroenterological Surgery, Peking University People's Hospital, Beijing, China.; Beijing Key Laboratory of Colorectal Cancer Diagnosis and Treatment Research, Beijing, China.
Li C; Department of Gastroenterological Surgery, Peking University People's Hospital, Beijing, China.; Beijing Key Laboratory of Colorectal Cancer Diagnosis and Treatment Research, Beijing, China.
Hou S; Department of Gastroenterological Surgery, Peking University People's Hospital, Beijing, China.; Beijing Key Laboratory of Colorectal Cancer Diagnosis and Treatment Research, Beijing, China.
Hu B; Department of Gastroenterological Surgery, Peking University People's Hospital, Beijing, China.; Beijing Key Laboratory of Colorectal Cancer Diagnosis and Treatment Research, Beijing, China.
Wang B; Department of Gastroenterological Surgery, Peking University People's Hospital, Beijing, China.; Laboratory of Surgical Oncology, Peking University People's Hospital, Beijing, China.; Beijing Key Laboratory of Colorectal Cancer Diagnosis and Treatment Research, Beijing, China.
Ye Y; Department of Gastroenterological Surgery, Peking University People's Hospital, Beijing, China. .; Laboratory of Surgical Oncology, Peking University People's Hospital, Beijing, China. .; Beijing Key Laboratory of Colorectal Cancer Diagnosis and Treatment Research, Beijing, China. .
Shen Z; Department of Gastroenterological Surgery, Peking University People's Hospital, Beijing, China. .; Laboratory of Surgical Oncology, Peking University People's Hospital, Beijing, China. .; Beijing Key Laboratory of Colorectal Cancer Diagnosis and Treatment Research, Beijing, China. .; Pokaż więcej
Źródło:: Journal of translational medicine [J Transl Med] 2024 Feb 16; Vol. 22 (1), pp. 158. Date of Electronic Publication: 2024 Feb 16.
Typ publikacji:: Journal Article
MeSH Terms:: Stomach Neoplasms*
Liver Neoplasms*
Animals ; Humans ; Tumor-Associated Macrophages ; CD8-Positive T-Lymphocytes ; Immunosuppressive Agents ; Tumor Microenvironment ; Osteopontin

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Heterogeneity-induced NGF-NGFR communication inefficiency promotes mitotic spindle disorganization in exhausted T cells through PREX1 suppression to impair the anti-tumor immunotherapy with PD-1 mAb in hepatocellular carcinoma.
Autorzy:: Wang X; Liver Disease Center, The Affiliated Hospital of Qingdao University, Qingdao, China.
Yang T; Liver Disease Center, The Affiliated Hospital of Qingdao University, Qingdao, China.; Academician Workstation, Changsha Medical University, Changsha, China.; Hunan Key Laboratory of the Research and Development of Novel Pharmaceutical Preparations, Changsha Medical University, Changsha, China.
Shi S; Liver Disease Center, The Affiliated Hospital of Qingdao University, Qingdao, China.
Xu C; Liver Disease Center, The Affiliated Hospital of Qingdao University, Qingdao, China.
Wang F; Liver Disease Center, The Affiliated Hospital of Qingdao University, Qingdao, China.
Dai D; Liver Disease Center, The Affiliated Hospital of Qingdao University, Qingdao, China.
Guan G; Liver Disease Center, The Affiliated Hospital of Qingdao University, Qingdao, China.
Zhang Y; Liver Disease Center, The Affiliated Hospital of Qingdao University, Qingdao, China.
Wang S; Liver Disease Center, The Affiliated Hospital of Qingdao University, Qingdao, China.
Wang J; Liver Disease Center, The Affiliated Hospital of Qingdao University, Qingdao, China.
Zhang B; Liver Disease Center, The Affiliated Hospital of Qingdao University, Qingdao, China.
Liu P; Liver Disease Center, The Affiliated Hospital of Qingdao University, Qingdao, China.
Bai X; Liver Disease Center, The Affiliated Hospital of Qingdao University, Qingdao, China.
Jin Y; Liver Disease Center, The Affiliated Hospital of Qingdao University, Qingdao, China.
Li X; Liver Disease Center, The Affiliated Hospital of Qingdao University, Qingdao, China.
Zhu C; Liver Disease Center, The Affiliated Hospital of Qingdao University, Qingdao, China.
Chen D; Liver Disease Center, The Affiliated Hospital of Qingdao University, Qingdao, China.; Beijing Institute of Hepatology, Capital Medical University, Beijing, China.
Xu Q; Liver Disease Center, The Affiliated Hospital of Qingdao University, Qingdao, China.; Academician Workstation, Changsha Medical University, Changsha, China.
Guo Y; Liver Disease Center, The Affiliated Hospital of Qingdao University, Qingdao, China.; Pokaż więcej
Źródło:: Cancer medicine [Cancer Med] 2024 Feb; Vol. 13 (3), pp. e6736. Date of Electronic Publication: 2024 Jan 10.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Hepatocellular*/therapy
Liver Neoplasms*/therapy
Animals ; Mice ; Humans ; Programmed Cell Death 1 Receptor ; T-Lymphocytes ; Immunotherapy ; Guanine Nucleotide Exchange Factors ; Nerve Tissue Proteins ; Receptors, Nerve Growth Factor

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Unraveling the underlying pathogenic factors driving nonalcoholic steatohepatitis and hepatocellular carcinoma: an in-depth analysis of prognostically relevant gene signatures in hepatocellular carcinoma.
Autorzy:: Ni Y; College of Integrated Chinese and Western Medicine (College of Life Sciences), Anhui University of Chinese Medicine, Hefei, China.
Lu M; College of Integrated Chinese and Western Medicine (College of Life Sciences), Anhui University of Chinese Medicine, Hefei, China.
Li M; College of Integrated Chinese and Western Medicine (College of Life Sciences), Anhui University of Chinese Medicine, Hefei, China.
Hu X; College of Integrated Chinese and Western Medicine (College of Life Sciences), Anhui University of Chinese Medicine, Hefei, China.
Li F; State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, China. .
Wang Y; College of Integrated Chinese and Western Medicine (College of Life Sciences), Anhui University of Chinese Medicine, Hefei, China. .
Xue D; College of Integrated Chinese and Western Medicine (College of Life Sciences), Anhui University of Chinese Medicine, Hefei, China. xue_dong_.; Pokaż więcej
Źródło:: Journal of translational medicine [J Transl Med] 2024 Jan 18; Vol. 22 (1), pp. 72. Date of Electronic Publication: 2024 Jan 18.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Hepatocellular*/pathology
Non-alcoholic Fatty Liver Disease*/genetics
Non-alcoholic Fatty Liver Disease*/metabolism
Liver Neoplasms*/pathology
Humans ; Models, Statistical ; Prognosis ; Disease Progression ; Fibrosis

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: UTP11 promotes the growth of hepatocellular carcinoma by enhancing the mRNA stability of Oct4.
Autorzy:: Chen Y; Department of Gastroenterology, The Second Affiliated Hospital of Shandong First Medical University, Tai an City, China.
Zhang X; Department of Gastroenterology, The Second Affiliated Hospital of Shandong First Medical University, Tai an City, China.
Zhang M; Department of Endoscopy Center, The Second Affiliated Hospital of Shandong First Medical University, Tai an City, China.
Fan W; Department of Gastrointestinal Surgery, The Second Affiliated Hospital of Shandong First Medical University, 271000, Tai an City, China.
Lin Y; Department of Endoscopy Center, The Second Affiliated Hospital of Shandong First Medical University, Tai an City, China.
Li G; Department of Gastrointestinal Surgery, The Second Affiliated Hospital of Shandong First Medical University, 271000, Tai an City, China. .; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2024 Jan 17; Vol. 24 (1), pp. 93. Date of Electronic Publication: 2024 Jan 17.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Hepatocellular*/pathology
Liver Neoplasms*/pathology
Animals ; Humans ; Mice ; Cell Line, Tumor ; Gene Expression Regulation, Neoplastic ; Prognosis ; RNA Stability ; RNA, Messenger/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: High-intensity focused ultrasound ablation combined with systemic therapy for unresectable colorectal cancer liver metastasis: A propensity score-matched analysis.
Autorzy:: Tang F; Department of Cancer Center, Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.; Department of Medical Oncology, Guizhou Province People's Hospital, Guiyang, China.
Zhong Q; Department of Medical Oncology, Guizhou Province People's Hospital, Guiyang, China.
Ni T; Department of Medical Oncology, Guizhou Province People's Hospital, Guiyang, China.
Xue Y; Department of Medical Oncology, Guizhou Province People's Hospital, Guiyang, China.
Wu J; Department of Medical Oncology, Guizhou Province People's Hospital, Guiyang, China.
Deng R; Department of Medical Oncology, Guizhou Province People's Hospital, Guiyang, China.
Zhang Q; Department of Medical Oncology, Guizhou Province People's Hospital, Guiyang, China.
Li Y; Department of Medical Oncology, Guizhou Province People's Hospital, Guiyang, China.
He X; Department of Medical Oncology, Guizhou Province People's Hospital, Guiyang, China.
Yang Z; Department of Cancer Center, Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.
Zhang Y; Department of Medical Oncology, Guizhou Province People's Hospital, Guiyang, China.; National Health Commission Key Laboratory of Pulmonary Immune-Related Diseases, Guizhou Province People's Hospital, Guiyang, China.; Pokaż więcej
Źródło:: Cancer medicine [Cancer Med] 2023 Dec; Vol. 12 (24), pp. 21985-21995. Date of Electronic Publication: 2023 Nov 30.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Liver Neoplasms*/pathology
High-Intensity Focused Ultrasound Ablation*/adverse effects
High-Intensity Focused Ultrasound Ablation*/methods
Colorectal Neoplasms*/pathology
Humans ; Retrospective Studies ; Propensity Score ; Treatment Outcome

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: HLA-DR genetic polymorphisms and hepatitis B virus mutations affect the risk of hepatocellular carcinoma in Han Chinese population.
Autorzy:: Zhao Y; Department of Infectious Diseases, Second Affiliated Hospital of Shandong First Medical University, 706 Taishan Street, Tai'an, Shandong Province, China.
Chen K; School of Public Health, Shandong First Medical University & Shandong Academy of Medical Sciences, 6699 Qingdao Road, Jinan, Shandong Province, China.
Yang H; School of Public Health, Shandong First Medical University & Shandong Academy of Medical Sciences, 6699 Qingdao Road, Jinan, Shandong Province, China.
Zhang F; Department of Gastrointestinal Surgery, Tai'an Central Hospital, 29 Longtan Road, Tai'an, Shandong Province, China.
Ding L; Department of Public Health, Jinan Central Hospital, 105 Jiefang Road, Jinan, Shandong Province, China.
Liu Y; School of Public Health, Shandong First Medical University & Shandong Academy of Medical Sciences, 6699 Qingdao Road, Jinan, Shandong Province, China.
Zhang L; School of Public Health, Shandong First Medical University & Shandong Academy of Medical Sciences, 6699 Qingdao Road, Jinan, Shandong Province, China.
Zhang Y; School of Public Health, Shandong First Medical University & Shandong Academy of Medical Sciences, 6699 Qingdao Road, Jinan, Shandong Province, China.
Wang H; Department of Infectious Diseases, Second Affiliated Hospital of Shandong First Medical University, 706 Taishan Street, Tai'an, Shandong Province, China.
Deng Y; School of Public Health, Shandong First Medical University & Shandong Academy of Medical Sciences, 6699 Qingdao Road, Jinan, Shandong Province, China. .; Pokaż więcej
Źródło:: Virology journal [Virol J] 2023 Nov 30; Vol. 20 (1), pp. 283. Date of Electronic Publication: 2023 Nov 30.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Hepatocellular*/genetics
Carcinoma, Hepatocellular*/virology
Hepatitis B virus*/genetics
Hepatitis B, Chronic*/genetics
Hepatitis B, Chronic*/virology
HLA-DR Antigens*/genetics
Liver Neoplasms*/genetics
Liver Neoplasms*/virology
Humans ; East Asian People ; Genetic Predisposition to Disease ; Genotype ; Mutation ; Polymorphism, Single Nucleotide

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: Macrophage metabolism, phenotype, function, and therapy in hepatocellular carcinoma (HCC).
Autorzy:: Huang J; Department of General Surgery, The Second Affiliated Hospital of Guangxi Medical University, Nanning, 530007, Guangxi, China.
Wu Q; Department of General Surgery, The Second Affiliated Hospital of Guangxi Medical University, Nanning, 530007, Guangxi, China.
Geller DA; Department of Surgery, Thomas E. Starzl Transplantation Institute, University of Pittsburgh Medical Center, Pittsburgh, PA, 15260, USA. .
Yan Y; Department of General Surgery, The Second Affiliated Hospital of Guangxi Medical University, Nanning, 530007, Guangxi, China. .; Pokaż więcej
Źródło:: Journal of translational medicine [J Transl Med] 2023 Nov 15; Vol. 21 (1), pp. 815. Date of Electronic Publication: 2023 Nov 15.
Typ publikacji:: Journal Article; Review; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:: Carcinoma, Hepatocellular*/genetics
Liver Neoplasms*/genetics
Humans ; Macrophages/metabolism ; Signal Transduction ; Phenotype ; Tumor Microenvironment

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: Intratumoral and peritumoral radiomics based on contrast-enhanced MRI for preoperatively predicting treatment response of transarterial chemoembolization in hepatocellular carcinoma.
Autorzy:: Zhao Y; Department of Radiology, The First Affiliated Hospital, Dalian Medical University, No. 222 Zhongshan Road, Xigang District, Dalian, Liaoning, China.
Zhang J; Department of Interventional Radiology, The First Affiliated Hospital, Dalian Medical University, Dalian, China.
Wang N; Department of Radiology, The First Affiliated Hospital, Dalian Medical University, No. 222 Zhongshan Road, Xigang District, Dalian, Liaoning, China.
Xu Q; Department of Radiology, The First Affiliated Hospital, Dalian Medical University, No. 222 Zhongshan Road, Xigang District, Dalian, Liaoning, China.
Liu Y; College of Medical Imaging, Dalian Medical University, Dalian, China.
Liu J; Department of Radiology, The First Affiliated Hospital, Dalian Medical University, No. 222 Zhongshan Road, Xigang District, Dalian, Liaoning, China.
Zhang Q; Department of Radiology, The First Affiliated Hospital, Dalian Medical University, No. 222 Zhongshan Road, Xigang District, Dalian, Liaoning, China.
Zhang X; College of Medical Imaging, Dalian Medical University, Dalian, China.
Chen A; Department of Radiology, The First Affiliated Hospital, Dalian Medical University, No. 222 Zhongshan Road, Xigang District, Dalian, Liaoning, China.
Chen L; Department of Radiology, The First Affiliated Hospital, Dalian Medical University, No. 222 Zhongshan Road, Xigang District, Dalian, Liaoning, China.
Sheng L; College of Medical Imaging, Dalian Medical University, Dalian, China.
Song Q; Department of Radiology, The First Affiliated Hospital, Dalian Medical University, No. 222 Zhongshan Road, Xigang District, Dalian, Liaoning, China.
Wang F; Department of Interventional Radiology, The First Affiliated Hospital, Dalian Medical University, Dalian, China.
Guo Y; GE Healthcare (China), Shanghai, China.
Liu A; Department of Radiology, The First Affiliated Hospital, Dalian Medical University, No. 222 Zhongshan Road, Xigang District, Dalian, Liaoning, China. .; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2023 Oct 24; Vol. 23 (1), pp. 1026. Date of Electronic Publication: 2023 Oct 24.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Hepatocellular*/diagnostic imaging
Carcinoma, Hepatocellular*/therapy
Chemoembolization, Therapeutic*
Liver Neoplasms*/diagnostic imaging
Liver Neoplasms*/therapy
Humans ; Retrospective Studies ; Magnetic Resonance Imaging

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: LncRNA FTO-IT1 promotes glycolysis and progression of hepatocellular carcinoma through modulating FTO-mediated N6-methyladenosine modification on GLUT1 and PKM2.
Autorzy:: Wang F; Department of Emergency Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hubei Province, 1277 Jiefang Avenue, Wuhan, 430022, People's Republic of China.
Hu Y; Department of Emergency Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hubei Province, 1277 Jiefang Avenue, Wuhan, 430022, People's Republic of China.
Wang H; Department of Emergency Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hubei Province, 1277 Jiefang Avenue, Wuhan, 430022, People's Republic of China.
Hu P; Department of Emergency Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hubei Province, 1277 Jiefang Avenue, Wuhan, 430022, People's Republic of China.
Xiong H; Department of Emergency Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hubei Province, 1277 Jiefang Avenue, Wuhan, 430022, People's Republic of China.
Zeng Z; Department of Emergency Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hubei Province, 1277 Jiefang Avenue, Wuhan, 430022, People's Republic of China.
Han S; Department of Emergency Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hubei Province, 1277 Jiefang Avenue, Wuhan, 430022, People's Republic of China.
Wang D; Department of Emergency Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hubei Province, 1277 Jiefang Avenue, Wuhan, 430022, People's Republic of China.
Wang J; Department of Emergency Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hubei Province, 1277 Jiefang Avenue, Wuhan, 430022, People's Republic of China.
Zhao Y; Department of Emergency Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hubei Province, 1277 Jiefang Avenue, Wuhan, 430022, People's Republic of China.
Huang Y; Department of Emergency Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hubei Province, 1277 Jiefang Avenue, Wuhan, 430022, People's Republic of China.
Zhuo W; Department of Emergency Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hubei Province, 1277 Jiefang Avenue, Wuhan, 430022, People's Republic of China.
Lv G; Department of Emergency Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hubei Province, 1277 Jiefang Avenue, Wuhan, 430022, People's Republic of China.
Zhao G; Department of Emergency Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hubei Province, 1277 Jiefang Avenue, Wuhan, 430022, People's Republic of China. .; Pokaż więcej
Źródło:: Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2023 Oct 16; Vol. 42 (1), pp. 267. Date of Electronic Publication: 2023 Oct 16.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Hepatocellular*/pathology
Liver Neoplasms*/pathology
RNA, Long Noncoding*/genetics
RNA, Long Noncoding*/metabolism
Animals ; Humans ; Alpha-Ketoglutarate-Dependent Dioxygenase FTO/genetics ; Alpha-Ketoglutarate-Dependent Dioxygenase FTO/metabolism ; Cell Line, Tumor ; Cell Proliferation/genetics ; Disease Models, Animal ; Gene Expression Regulation, Neoplastic ; Glucose Transporter Type 1/genetics ; Glycolysis ; RNA, Messenger/metabolism ; Thyroid Hormone-Binding Proteins

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: Comparative analysis of disease modelling for health economic evaluations of systemic therapies in advanced hepatocellular carcinoma.
Autorzy:: Zou H; State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao SAR, China.
Xue Y; State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao SAR, China.
Chen X; State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao SAR, China.
Lai Y; School of Public Health and Management, Guangzhou University of Chinese Medicine, Guangzhou, China.
Yao D; Department of Drug Regulatory Science and Pharmacoeconomics, School of Pharmacy, Nanjing Medical University, Nanjing, China.
Ung COL; State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao SAR, China.; Centre for Pharmaceutical Regulatory Sciences, University of Macau, Macao SAR, China.; Department of Public Health and Medicinal Administration, Faculty of Health Sciences, University of Macau, Macao SAR, China.
Hu H; State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao SAR, China.; Centre for Pharmaceutical Regulatory Sciences, University of Macau, Macao SAR, China.; Department of Public Health and Medicinal Administration, Faculty of Health Sciences, University of Macau, Macao SAR, China.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2023 Oct 05; Vol. 18 (10), pp. e0292239. Date of Electronic Publication: 2023 Oct 05 (Print Publication: 2023).
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Carcinoma, Hepatocellular*/therapy
Liver Neoplasms*/therapy
Humans ; Cost-Benefit Analysis ; Australia ; Canada

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: Tumour-derived exosomes in liver metastasis: A Pandora's box.
Autorzy:: Li S; National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Qu Y; National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Liu L; National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.; CAMS Key Laboratory of Translational Research on Lung Cancer, State Key Laboratory of Molecular Oncology, Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Wang C; National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Yuan L; National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Bai H; National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.; CAMS Key Laboratory of Translational Research on Lung Cancer, State Key Laboratory of Molecular Oncology, Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Wang J; National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.; CAMS Key Laboratory of Translational Research on Lung Cancer, State Key Laboratory of Molecular Oncology, Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.; Pokaż więcej
Źródło:: Cell proliferation [Cell Prolif] 2023 Oct; Vol. 56 (10), pp. e13452. Date of Electronic Publication: 2023 Mar 20.
Typ publikacji:: Systematic Review; Journal Article; Review
MeSH Terms:: Exosomes*/pathology
Liver Neoplasms*/pathology
Humans ; Cell Communication ; Pancreas/pathology ; Biomarkers, Tumor ; Tumor Microenvironment ; Neoplasm Metastasis/pathology

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: A Case of Curative Treatment with Apatinib and Camrelizumab Following Liver Resection for Advanced Hepatocellular Carcinoma.
Autorzy:: Huang J; Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning 530021, China.
Liang R; Department of Digestive Oncology, Guangxi Medical University Cancer Hospital, Nanning 530021, China.
Lu C; Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning 530021, China.
Lu L; Department of Digestive Oncology, Guangxi Medical University Cancer Hospital, Nanning 530021, China.
Li S; Department of Digestive Oncology, Guangxi Medical University Cancer Hospital, Nanning 530021, China.
Tang M; Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning 530021, China.
Huang X; Department of Digestive Oncology, Guangxi Medical University Cancer Hospital, Nanning 530021, China.
Huang S; Department of Digestive Oncology, Guangxi Medical University Cancer Hospital, Nanning 530021, China.
Mai R; Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning 530021, China.
Gao X; Department of Digestive Oncology, Guangxi Medical University Cancer Hospital, Nanning 530021, China.
Li S; Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning 530021, China.
Zeng C; Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning 530021, China.
Lin Y; Department of Digestive Oncology, Guangxi Medical University Cancer Hospital, Nanning 530021, China.
Ye J; Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning 530021, China.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2023 Aug 30; Vol. 24 (17). Date of Electronic Publication: 2023 Aug 30.
Typ publikacji:: Case Reports
MeSH Terms:: Carcinoma, Hepatocellular*/drug therapy
Carcinoma, Hepatocellular*/surgery
Liver Neoplasms*/drug therapy
Humans ; Hepatectomy ; Prospective Studies ; Neoplasm Recurrence, Local/drug therapy

Raport

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: Targeted delivery of a PD-1-blocking scFv by CD133-specific CAR-T cells using nonviral Sleeping Beauty transposition shows enhanced antitumour efficacy for advanced hepatocellular carcinoma.
Autorzy:: Yang C; Department of Experimental Research, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, 510060, People's Republic of China.; Department of Biotherapy, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, 510060, People's Republic of China.
You J; Department of Experimental Research, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, 510060, People's Republic of China.; Department of Biotherapy, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, 510060, People's Republic of China.
Pan Q; Department of Experimental Research, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, 510060, People's Republic of China.; Department of Biotherapy, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, 510060, People's Republic of China.
Tang Y; Department of Experimental Research, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, 510060, People's Republic of China.; Department of Biotherapy, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, 510060, People's Republic of China.
Cai L; International Institute for Translational Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, 510060, People's Republic of China.
Huang Y; Department of Experimental Research, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, 510060, People's Republic of China.; Department of Biotherapy, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, 510060, People's Republic of China.
Gu J; Department of Experimental Research, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, 510060, People's Republic of China.; Department of Molecular Diagnostics, Sun Yat-Sen University, Cancer Center, Guangzhou, Guangdong, 510060, People's Republic of China.
Wang Y; Department of Experimental Research, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, 510060, People's Republic of China.; Department of Thoracic Surgery, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, 510060, People's Republic of China.
Yang X; Department of Experimental Research, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, 510060, People's Republic of China.; Department of Biotherapy, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, 510060, People's Republic of China.
Du Y; Department of Experimental Research, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, 510060, People's Republic of China.; Department of Biotherapy, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, 510060, People's Republic of China.
Ouyang D; Department of Experimental Research, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, 510060, People's Republic of China.; Department of Biotherapy, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, 510060, People's Republic of China.
Chen H; Department of Experimental Research, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, 510060, People's Republic of China.; Department of Biotherapy, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, 510060, People's Republic of China.
Zhong H; Department of Experimental Research, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, 510060, People's Republic of China.
Li Y; Department of Experimental Research, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, 510060, People's Republic of China.; Department of Biotherapy, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, 510060, People's Republic of China.
Yang J; Department of Experimental Research, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, 510060, People's Republic of China.; Department of Biotherapy, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, 510060, People's Republic of China.
Han Y; Department of Experimental Research, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, 510060, People's Republic of China.; Department of Biotherapy, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, 510060, People's Republic of China.
Sun F; Department of Experimental Research, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, 510060, People's Republic of China.; Department of Biotherapy, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, 510060, People's Republic of China.
Chen Y; Department of Experimental Research, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, 510060, People's Republic of China.; Department of Biotherapy, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, 510060, People's Republic of China.
Wang Q; Department of Experimental Research, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, 510060, People's Republic of China.; Department of Biotherapy, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, 510060, People's Republic of China.
Weng D; Department of Experimental Research, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, 510060, People's Republic of China.; Department of Biotherapy, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, 510060, People's Republic of China.
Liu Z; International Institute for Translational Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, 510060, People's Republic of China. .
Xiang T; Department of Experimental Research, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, 510060, People's Republic of China. .; Department of Biotherapy, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, 510060, People's Republic of China. .
Xia J; Department of Experimental Research, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, 510060, People's Republic of China. .; Department of Biotherapy, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, 510060, People's Republic of China. .; Pokaż więcej
Źródło:: BMC medicine [BMC Med] 2023 Aug 28; Vol. 21 (1), pp. 327. Date of Electronic Publication: 2023 Aug 28.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Carcinoma, Hepatocellular*/genetics
Carcinoma, Hepatocellular*/therapy
Receptors, Chimeric Antigen*/genetics
Liver Neoplasms*/genetics
Liver Neoplasms*/therapy
Humans ; Male ; Animals ; Mice ; Programmed Cell Death 1 Receptor ; Disease Models, Animal ; T-Lymphocytes

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: Association of meat consumption with the risk of gastrointestinal cancers: a systematic review and meta-analysis.
Autorzy:: Di Y; Department of Medical Oncology, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
Ding L; Department of Oncology Surgery/ Beijing Shijitan Hospital, Capital Medical University, Beijing, China. .
Gao L; Department of Ultrasond/Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Huang H; Department of Medical Oncology, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2023 Aug 23; Vol. 23 (1), pp. 782. Date of Electronic Publication: 2023 Aug 23.
Typ publikacji:: Meta-Analysis; Systematic Review; Journal Article
MeSH Terms:: Carcinoma, Hepatocellular*
Liver Neoplasms*
Gastrointestinal Neoplasms*/epidemiology
Gastrointestinal Neoplasms*/etiology
Stomach Neoplasms*
Colonic Neoplasms*
Humans ; Prospective Studies ; Meat/adverse effects

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Yan, Y"" wg kryterium: Autor

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język